[Erythrocyte transfusion: update of the guidelines "therapy with blood components and plasma derivatives"].
The new version of the guidelines, which have now been renamed Cross-sectional guidelines on therapy with blood components and plasma derivatives, is distinguished by focusing on key recommendations. In each section clear recommendations for the selection and indications for the use of each blood product are presented and these recommendations are classified with respect to their strength and evidence level. The most important recommendations in section 1 "Erythrocyte concentrates", which is especially important for the faculty of anesthesiology, will be presented in this article with special reference to the data on which the recommendations are based.
Welte
M
M
Institut für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Klinikum Darmstadt, Grafenstrasse 9, 64283, Darmstadt, Deutschland. martin.welte@klinikum-darmstadt.de
D000740:Anemia / Q000097:blood / Q000628:therapy; D016913:Blood Component Transfusion / Q000592:standards*; D017707:Erythrocyte Transfusion / Q000592:standards*; D017408:Guidelines as Topic; D006801:Humans; D010949:Plasma